Reported rates of all-cause serious adverse events following immunization with BNT-162b in 5-17-year-old children in the United States.

Autor: Mangat HS; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, United States of America., Rippon B; Department of Population Health Sciences, Weill Cornell Medical College, New York, New York, United States of America., Reddy NT; Department of Medical Sciences, Newcastle University, Great Britain, Newcastle upon Tyne, United Kingdom., Syed AA; Faculty of Biology Medicine and Health, The University of Manchester, Manchester, United Kingdom., Maruthanal JM; Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, United States of America., Luedtke S; Gesundheitsamt Nuremberg, Nuremberg, Germany., Puthumana JJ; Department of Cardiology, Northwestern Medicine, Chicago, Illinois, United States of America., Srivatsa A; Department of Pediatrics, Boston's Children's Hospital, Boston, Massachusetts, United States of America., Bosman A; Transmissible BV, Public Health Learning Solutions, Utrecht, The Netherlands., Kostkova P; UCL Centre for Public Health in Emergencies (dPHE), University College London, London, United Kingdom.

Publikováno v: PloS one [PLoS One] 2023 Feb 17; Vol. 18 (2), pp. e0281993. Date of Electronic Publication: 2023 Feb 17 (Print Publication: 2023).